A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Dose-finding, Phase 2 Study to Assess the Efficacy and Safety of HD-6277 in Adult Patients With Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 2
SUMMARY
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Dose-finding, Phase 2 Study to Assess the Efficacy and Safety of HD-6277 in Adult Patients with Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise
Eligibility
Participation Requirements
Sex: All
Minimum Age: 19
Maximum Age: 75
Healthy Volunteers: f
View:
• Diagnosis of T2DM with HbA1c between 7.0% and 10.0% (inclusive) while on diet and exercise alone for at least 8 weeks prior to screening.
Locations
Other Locations
Republic of Korea
Korea University Anam Hospital
RECRUITING
Seoul
Contact Information
Primary
Sin Gon Kim Korea University Anam Hospital, PhD
k50367@korea.ac.kr
+82 1577-0083
Time Frame
Start Date: 2024-12-12
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 160
Treatments
Experimental: HD-6277 100mg tab
Oral tablet
Experimental: HD-6277 50mg tab
Oral tablet
Experimental: HD-6277 25mg tab
Oral tablet
Placebo_comparator: Placebo
Oral tablet
Related Therapeutic Areas
Sponsors
Leads: Hyundai Pharm